| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR SER TR | 100,000 | 22,550,000 | 8.11% | Put | |
| 2 | ZIMMER BIOMET HLDGS INC | 100,000 | 11,752,000 | 4.23% | ||
| 3 | ALLERGAN PLC | 35,000 | 10,417,000 | 3.75% | ||
| 4 | ENDO HEALTH SOLUTIONS INC | 90,000 | 8,073,000 | 2.90% | ||
| 5 | COMMUNITY HEALTH SYS INC NEW COM | 150,000 | 7,842,000 | 2.82% | ||
| 6 | NUVASIVE INC COM | 160,000 | 7,358,000 | 2.65% | ||
| 7 | PUMA BIOTECHNOLOGY | 30,000 | 7,083,000 | 2.55% | ||
| 8 | ZS PHARMA INC | 165,000 | 6,943,000 | 2.50% | ||
| 9 | ZELTIQ AESTHETICS INCORPORATED | 225,000 | 6,937,000 | 2.49% | ||
| 10 | CELGENE CORP | 60,000 | 6,917,000 | 2.49% | ||
| 11 | PORTOLA PHARMACEUTICALS INC | 180,000 | 6,833,000 | 2.46% | ||
| 12 | SAGE THERAPEUTICS | 120,000 | 6,028,000 | 2.17% | ||
| 13 | DYAX CORP COM CVR | 350,000 | 5,864,000 | 2.11% | ||
| 14 | MERIT MED SYS INC COM | 300,000 | 5,775,000 | 2.08% | ||
| 15 | MERCK & CO INC | 100,000 | 5,748,000 | 2.07% | ||
| 16 | WRIGHT MEDICAL GROUP NV | 200,000 | 5,160,000 | 1.86% | ||
| 17 | BECTON DICKINSON & CO | 35,000 | 5,026,000 | 1.81% | ||
| 18 | GENOCEA BIOSCIENCES INC | 420,000 | 4,981,000 | 1.79% | ||
| 19 | NUVASIVE INC COM | 100,000 | 4,599,000 | 1.65% | Call | |
| 20 | ALCOBRA LTD | 800,000 | 4,504,000 | 1.62% | ||
| 21 | AVALANCHE BIOTECHNOLOGIES IN | 110,000 | 4,457,000 | 1.60% | ||
| 22 | BIOMARIN | 35,000 | 4,362,000 | 1.57% | ||
| 23 | Sunesis Pharmaceuticals I | 1,750,000 | 4,288,000 | 1.54% | ||
| 24 | CEPHEID | 75,000 | 4,268,000 | 1.53% | ||
| 25 | ALNYLAM PHARMACEUTICALS INC | 40,000 | 4,177,000 | 1.50% | ||
| 26 | AGILENT TECHNOLOGIES INC | 100,000 | 4,155,000 | 1.49% | Call | |
| 27 | REVANCE THERAPEUTICS INC COM | 200,000 | 4,146,000 | 1.49% | ||
| 28 | GW PHARMACEUTICALS PLC | 45,000 | 4,101,000 | 1.47% | ||
| 29 | ABBVIE INC | 70,000 | 4,098,000 | 1.47% | ||
| 30 | AVALANCHE BIOTECHNOLOGIES IN | 100,000 | 4,052,000 | 1.46% | Call | |
| 31 | ACADIA PHARMACEUTICALS INC COM | 120,000 | 3,911,000 | 1.41% | ||
| 32 | EXACT SCIENCES CORP | 175,000 | 3,854,000 | 1.39% | ||
| 33 | AMICUS THERAPEUTICS INC | 350,000 | 3,808,000 | 1.37% | ||
| 34 | ACHILLION PHARMACEUTICALS INC COM | 375,000 | 3,698,000 | 1.33% | ||
| 35 | PTC THERAPEUTICS INC | 60,000 | 3,651,000 | 1.31% | ||
| 36 | THERAPEUTICSMD INC | 600,000 | 3,630,000 | 1.31% | ||
| 37 | BLUEBIRD BIO INCORPORATED | 30,000 | 3,623,000 | 1.30% | ||
| 38 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 200,000 | 3,596,000 | 1.29% | ||
| 39 | INOGEN INC COM | 110,000 | 3,519,000 | 1.27% | ||
| 40 | VITAE PHARMACEUTICALS INC | 300,000 | 3,513,000 | 1.26% | ||
| 41 | DBV TECHNOLOGIES | 150,000 | 3,504,000 | 1.26% | ||
| 42 | NANOSTRING TECHNOLOGIES INC | 335,000 | 3,414,000 | 1.23% | ||
| 43 | ENTELLUS MEDICAL INC | 150,000 | 3,285,000 | 1.18% | ||
| 44 | RADIUS HEALTH | 75,000 | 3,087,000 | 1.11% | ||
| 45 | DISCOVERY LABORATORIES INC N | 2,500,000 | 2,975,000 | 1.07% | ||
| 46 | PERNIX THERAPEUTICS HLDGS IN | 250,000 | 2,673,000 | 0.96% | ||
| 47 | IGNYTA INC COM | 250,000 | 2,488,000 | 0.89% | ||
| 48 | Lion Biotechnologies | 200,000 | 2,422,000 | 0.87% | ||
| 49 | TETRAPHASE PHARMACEUTICALS I COM | 65,000 | 2,382,000 | 0.86% | ||
| 50 | APPLIED GENETIC TECHNOL CORP | 116,750 | 2,334,000 | 0.84% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-15-020402, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
